勘误：脑脊液中的生长抑素和神经肽Y：与轻度认知障碍老年患者淀粉样肽Aβ和 Tau 蛋白的相关性
Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß, and Tau Proteins in Elderly Patients With Mild Cognitive Impairment.
作者信息
Duron Emmanuelle, Vidal Jean-Sébastien, Grousselle Dominique, Gabelle Audrey, Lehmann Sylvain, Pasquier Florence, Bombois Stéphanie, Buée Luc, Allinquant Bernadette, Schraen-Maschke Susanna, Baret Christiane, Rigaud Anne-Sophie, Hanon Olivier, Epelbaum Jacques
机构信息
AP-HP, Hôpital Broca, Service de Gériatrie, Paris, France.
Université Sorbonne Paris Cité, UMR-S894, INSERM Université Paris Descartes, Centre de Psychiatrie et Neuroscience, Paris, France.
出版信息
Front Aging Neurosci. 2019 Feb 19;11:11. doi: 10.3389/fnagi.2019.00011. eCollection 2019.
Abstract
[This corrects the article DOI: 10.3389/fnagi.2018.00297.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fnagi.2018.00297。]
相似文献
1
Corrigendum: Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aß, and Tau Proteins in Elderly Patients With Mild Cognitive Impairment.
Front Aging Neurosci. 2019 Feb 19;11:11. doi: 10.3389/fnagi.2019.00011. eCollection 2019.
2
Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ and Tau Proteins in Elderly Patients With Mild Cognitive Impairment.
Front Aging Neurosci. 2018 Oct 1;10:297. doi: 10.3389/fnagi.2018.00297. eCollection 2018.
3
Interactions between amyloid-β and tau in cerebrospinal fluid of people with mild cognitive impairment and Alzheimer's disease.
J Alzheimers Dis. 2014;42 Suppl 3:S91-8. doi: 10.3233/JAD-132393.
4
Corrigendum: A Pilot Study on the Cutoff Value of Related Brain Metabolite in Chinese Elderly Patients With Mild Cognitive Impairment Using MRS.
Front Aging Neurosci. 2021 Oct 12;13:759482. doi: 10.3389/fnagi.2021.759482. eCollection 2021.
5
Corrigendum: Behavioral and Neuroimaging Evidence for Facial Emotion Recognition in Elderly Korean Adults with Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia.
Front Aging Neurosci. 2019 Apr 24;11:91. doi: 10.3389/fnagi.2019.00091. eCollection 2019.
6
Corrigendum: The Effects of a Magic Intervention Program on Cognitive Function and Neurocognitive Performance in Elderly Individuals With Mild Cognitive Impairment.
Front Aging Neurosci. 2022 Jul 13;14:963605. doi: 10.3389/fnagi.2022.963605. eCollection 2022.
7
Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.
Arch Neurol. 2002 Nov;59(11):1729-34. doi: 10.1001/archneur.59.11.1729.
8
Changes of cerebrospinal fluid Aβ, t-tau, and p-tau in Parkinson's disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis.
Neurol Sci. 2017 Nov;38(11):1953-1961. doi: 10.1007/s10072-017-3088-1. Epub 2017 Aug 14.
9
Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.
Arch Neurol. 1988 Mar;45(3):269-74. doi: 10.1001/archneur.1988.00520270043019.
10
Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
Bipolar Disord. 2016 Feb;18(1):63-70. doi: 10.1111/bdi.12360. Epub 2016 Feb 15.
引用本文的文献
1
Decoding Precision Aging: The Intersection of Cognitive Decline, Frailty, and Hormonal Biomarkers.
Gerontology. 2025;71(7):564-575. doi: 10.1159/000546250. Epub 2025 May 5.
2
Functional identification of two novel variants and a hypomorphic variant in from patients with Citrullinemia type I.
Front Genet. 2023 Jul 7;14:1172947. doi: 10.3389/fgene.2023.1172947. eCollection 2023.
Zotero 插件